Asbestos-related pleuropulmonary diseases: Benign and malignant

Angeline Lazarus*, Ali Massoumi, Jordanna Hostler, David C. Hostler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Asbestos is known for its desirable properties of thermal and heat resistance along with excellent strength and durability. It was widely used in many industries since the late 19th century, until its adverse effects on health were recognized. The occurrence of pleuropulmonary changes from exposure to asbestos often has a latency period of 20 to 30 years. The use of asbestos has been banned, regulated, and minimized in many countries, but in several developing countries, the use of asbestos in industries is still a common practice. In this article, the benign and malignant clinical manifestations of asbestos exposure are discussed.

Original languageEnglish
Pages (from-to)116-130
Number of pages15
JournalPostgraduate Medicine
Issue number3
StatePublished - May 2012
Externally publishedYes


  • Asbestos
  • Asbestosis
  • Lung cancer
  • Pleural effusion
  • Pleural thickening
  • Pleuropulmonary disease


Dive into the research topics of 'Asbestos-related pleuropulmonary diseases: Benign and malignant'. Together they form a unique fingerprint.

Cite this